Back
Intellia Therapeutics Quote, Financials, Valuation and Earnings

Introducing The Great $2 AI Moonshot
Open your free presentation now
Sell
16
NTLA
Intellia Therapeutics
Last Price:
31.61
Seasonality Move:
10.55%
7 Day Trial
ALL ACCESS PASS
$
7

Wall Street Caliber A.I. for the "Little Guy"
Get the full story hereIntellia Therapeutics Price Quote
$31.61
+0.01 (+-0.47%)
(Updated: September 30, 2023 at 5:52 AM ET)
Intellia Therapeutics Key Stats
Sell
16
Intellia Therapeutics (NTLA)
is a Sell
Day range:
$31.39 - $32.47
52-week range:
$31.13 - $63.12
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
49.64
P/B ratio:
2.53%
Volume:
600.5K
Avg. volume:
751.6K
1-year change:
-42.85%
Market cap:
$2.8B
Revenue:
$52.1M
EPS:
$-5.46
How Much Does Intellia Therapeutics Make?
-
How Much Are Intellia Therapeutics's Sales Annually?
NTLA Revenues are $52.1M -
How Much Profit Does Intellia Therapeutics's Make A Year?
NTLA net income is -$474.2M
Is Intellia Therapeutics Growing As A Company?
-
What Is Intellia Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.03% -
What Is Intellia Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Intellia Therapeutics Stock Price Performance
-
Did Intellia Therapeutics Stock Go Up Last Month?
Intellia Therapeutics share price went down by -17.26% last month -
Did NTLA's Share Price Rise Over The Last Year?
NTLA share price fell by -42.85% over the past 1 year
What Is Intellia Therapeutics 52-Week High & Low?
-
What Is Intellia Therapeutics’s 52-Week High Share Price?
Intellia Therapeutics has traded as high as $63.12 over the past 52 weeks -
What Is Intellia Therapeutics’s 52-Week Low Share Price?
Intellia Therapeutics has traded as low as $31.13 over the past 52 weeks
Intellia Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Intellia Therapeutics?
-
How Much Debt Does Intellia Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Intellia Therapeutics Have?
Cash and short term investments quarterly total is $908.1M -
What Is Intellia Therapeutics’s Book Value Per Share?
Book value per share is 12.51
Is Intellia Therapeutics Cash Flow Positive?
-
What Is NTLA Cash Flow From Operations?
Cash flow from operations (TTM) is -$368M -
What Is Intellia Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $534.5M -
What Is Intellia Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$139.3M
Intellia Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
NTLA return on invested capital is -43.29% -
What Is Intellia Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -35.12% -
What Is NTLA Return On Equity?
ROE is a measure of profitability and is -43.29%
Intellia Therapeutics Earnings Date & Stock Price
-
What Is Intellia Therapeutics's Stock Price Today?
A single share of NTLA can be purchased today for 31.60 -
What Is Intellia Therapeutics’s Stock Symbol?
Intellia Therapeutics trades on the nasdaq under the ticker symbol: NTLA -
When Is Intellia Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Intellia Therapeutics is scheduled on November 3, 2023 -
When Is NTLA's next ex-dividend date?
Intellia Therapeutics's next ex-dividend date is October 1, 2023 -
How To Buy Intellia Therapeutics Stock?
You can buy Intellia Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Intellia Therapeutics Competitors
-
Who Are Intellia Therapeutics's Competitors?
Below is a list of companies who compete with Intellia Therapeutics or are related in some way:
Intellia Therapeutics Dividend Yield
Data Unavailable
Intellia Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -5.43% |
Revenue: | -3.11% | 20.14% |
Analyst Recommendations
Buy Recommendations: | 17 |
---|---|
Hold Recommendations: | 4 |
Sell Recommendations: | 0 |
Price Target: | 85.08 |
Upside from Last Price: | 169.24% |